PubRank

C D Ward

Author PubWeight™ 41.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology 1997 3.58
2 A community-dwelling sample of people with Parkinson's disease: characteristics of fallers and non-fallers. Age Ageing 2001 3.13
3 Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology 1983 2.47
4 Observations during transient global amnesia. A behavioural and neuropsychological study of five cases. Brain 1989 1.69
5 Cloning of the Escherichia coli release factor 2 gene. J Bacteriol 1984 1.56
6 Predicting fallers in a community-based sample of people with Parkinson's disease. Gerontology 2001 1.37
7 A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke 2000 1.31
8 Olfactory impairment in Parkinson's disease. Neurology 1983 1.30
9 On autonomy and participation in rehabilitation. Disabil Rehabil 2002 1.21
10 Molecular cloning of the NP and L genes of simian virus 5: identification of highly conserved domains in paramyxovirus NP and L proteins. Virus Res 1992 1.09
11 Long-term effects of repeated plasma exchange in myasthenia gravis. Lancet 1979 1.07
12 Pleuropulmonary and retroperitoneal fibrosis associated with bromocriptine treatment. J Neurol Neurosurg Psychiatry 1987 0.98
13 Generalised botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two cases. J Neurol Neurosurg Psychiatry 1997 0.94
14 The ribosomal binding domain for the bacterial release factors RF-1, RF-2 and RF-3. FEBS Lett 1984 0.94
15 Comparison of pergolide and bromocriptine therapy in parkinsonism. Neurology 1983 0.93
16 Measuring autonomy in disabled people: Validation of a new scale in a UK population. Clin Rehabil 2006 0.90
17 Encephalitis lethargica and the development of neuropsychiatry. Psychiatr Clin North Am 1986 0.87
18 Lisuride in parkinsonism. Neurology 1981 0.87
19 Parkinson's disease in twins. Adv Neurol 1984 0.85
20 Retinol binding protein as a small molecular weight marker of renal tubular function in diabetes mellitus. Ann Clin Biochem 1987 0.85
21 Goal-setting in rehabilitation: report of a workshop to explore professionals' perceptions of goal-setting. Clin Rehabil 2000 0.83
22 Hypokalaemic paralysis. Br Med J 1978 0.82
23 Neurological rehabilitation in Indonesia and the UK: differences and similarities. J Allied Health 1998 0.81
24 [Plasmapheresis for myasthenia gravis]. N Engl J Med 1978 0.81
25 Decision-making in refractory epilepsy: an analysis based on computer simulation. J Neurol Neurosurg Psychiatry 1986 0.81
26 Effect of temperature on neuromuscular transmission in the Eaton-Lambert syndrome. J Neurol Neurosurg Psychiatry 1979 0.81
27 The ribosomal binding domain of the Escherichia coli release factors. Modification of tyrosine in the N-terminal domain of ribosomal protein L11 affects release factors 1 and 2 differentially. J Biol Chem 1986 0.80
28 A double-blind, cross-over, study of oral N-acetylcysteine in Sjögren's syndrome. Scand J Rheumatol Suppl 1986 0.80
29 Problems of interference in the PABA test for assessment of pancreatic exocrine function. Clin Chem 1985 0.79
30 Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind study. Neurology 1982 0.79
31 L-dopa decarboxylation in chronically treated patients. Neurology 1984 0.79
32 The differential positive rate, a derivative of receiver operating characteristic curves useful in comparing tests and determining decision levels. Clin Chem 1986 0.78
33 Retrieval from semantic and letter-initial categories in patients with Parkinson's disease. Neuropsychologia 1989 0.77
34 Methods for evaluating treatment in Parkinson's disease. Adv Neurol 1983 0.76
35 Treatment of myoclonus with pheneturide. J Neurol Neurosurg Psychiatry 1978 0.75
36 Effect of immobilisation on position and movement sense of the knee. J Neurol Neurosurg Psychiatry 1994 0.75
37 What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000 0.75
38 The Shine and Dalgarno hypothesis for termination: the 3' terminus of the 16S rRNA of the Escherichia coli ribosome can be modified or base-paired with a complementary oligonucleotide without affecting termination in vitro. Biochem Int 1983 0.75
39 Parkinson's disease and the frontal hypothesis: task alternation in verbal fluency. Adv Neurol 1990 0.75
40 Own height, sex, and liking in the judgment of the heights of others. J Pers 1967 0.75
41 Seating arrangement and leadership emergence in small discussion groups. J Soc Psychol 1968 0.75
42 Persuasibility as a function of source credibility and locus of control: five cross cultural experiments. J Pers 1974 0.75
43 Ribosomes from a relC mutant strain of Escherichia coli show altered activity with bacterial release factor-1. Biochem Int 1985 0.75
44 Evaluation of the dizzy patient. Ear Nose Throat J 1984 0.75
45 Birth order and dreams. J Soc Psychol 1973 0.75
46 Does abnormal stimulus processing contribute to delayed motor response in Parkinson's disease? Adv Neurol 1993 0.75
47 Tissue fluoroacetate residues in prairie dogs dosed with low-level sodium monofluoroacetate. J Assoc Off Anal Chem 1988 0.75
48 Comparison of methods of correction for interference in the PABA test for exocrine pancreatic function. Clin Chem 1986 0.75
49 Evaluation of text telephones designed for people with impaired hearing or speech. J Med Eng Technol 2005 0.75
50 Attitude and involvement in the absolute judgment of attitude statements. J Pers Soc Psychol 1966 0.75
51 The Ecumenical Council and attitude change among Catholic, Protestant, and Jewish college students. J Soc Psychol 1968 0.75